Evidence map›Paper›PMID 22828569›Full record

ArticleJournal of theoretical biology2012

Realistic enzymology for post-translational modification: zero-order ultrasensitivity revisited.

Yangqing Xu, Jeremy Gunawardena

Abstract read
In one paragraph

Article in Journal of theoretical biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Laplacian Dynamics with Synthesis and Degradation.Bulletin of mathematical biology · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yangqing XuDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Jeremy Gunawardena

Funding

Complex Dynamics in Multisite PhosphorylationR01GM081578 · NIGMS · HARVARD MEDICAL SCHOOL · PI GUNAWARDENA, JEREMY · 2008 to 2011
$1.4M
NIGMS NIH HHS R01 GM081578NIGMS NIH HHS R01GM081578
6 · The paper itself

Abstract

Unlimited ultrasensitivity in a kinase/phosphatase "futile cycle" has been a paradigmatic example of collective behaviour in multi-enzyme systems. However, its analysis has relied on the Michaelis-Menten reaction mechanism, which remains widely used despite a century of new knowledge. Modifying and demodifying enzymes accomplish different biochemical tasks; the donor that contributes the modifying group is often ignored without the impact of this time-scale separation being taken into account; and new forms of reversible modification are now known. We exploit new algebraic methods of steady-state analysis to reconcile the analysis of multi-enzyme systems with single-enzyme biochemistry using zero-order ultrasensitivity as an example. We identify the property of "strong irreversibility", in which product re-binding is disallowed. We show that unlimited ultrasensitivity is preserved for a class of complex, strongly irreversible reaction mechanisms and determine the corresponding saturation conditions. We show further that unlimited ultrasensitivity arises from a singularity in a novel "invariant" that summarises the algebraic relationship between modified and unmodified substrate. We find that this singularity also underlies knife-edge behaviour in allocation of substrate between modification states, which has implications for the coherence of futile cycles within an integrated tissue. When the enzymes are irreversible, but not strongly so, the singularity disappears in the form found here and unlimited ultrasensitivity may no longer be preserved. The methods introduced here are widely applicable to other reversible modification systems.

Indexed as

Models, BiologicalPhosphoprotein PhosphatasesProtein KinasesProtein Modification, TranslationalPhosphoprotein PhosphatasesProtein Kinases

Identifiers

PMID22828569
PMCPMC3432734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.